Size: 553.65 KB
Date added: 20/02/2024 06:25:11
Last modified on: 21/02/2024 06:50:15
Version: 5.3
Hits: 3301
In response to a critical shortage of intramuscular (IM) glucagon, intranasal (IN) glucagon has been approved and added to the Hypoglycemia Medical Directive. The MOH released this on February 9, 2024, in the Advanced Life Support Patient Care Standards v5.3.
